VAERS reports by lot

Pfizer COVID-19 lot EWO177: VAERS reports

41 VAERS reports list lot EWO177 as a Pfizer COVID-19 vaccine, received between 2021-05-17 and 2022-08-10. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
41
Reports
12%
Marked serious
1
With a death outcome
11
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Cardiac / Cardiovascular4021%
General / Systemic (non-local)3921%
Neurological3016%
Gastrointestinal158%
Respiratory137%
Musculoskeletal116%
Dermatological (non-injection-site)105%
Reproductive / Menstrual95%
Injection-site / Local reaction95%
Allergic / Anaphylactic42%
Thrombotic / Hematological32%
Autoimmune / Immune-mediated21%
Psychiatric / Neuropsychiatric21%

Where reports came from

U.S. state of the reporter, where given (top 12).

California8
Florida5
New York4
Texas4
Virginia3
Massachusetts3
Oregon2
New Jersey2
Pennsylvania2
Washington2
Arizona1
Alabama1

Reports by month received

2021-054
2021-0611
2021-0710
2021-086
2021-091
2021-102
2021-111
2021-122
2022-032
2022-071
2022-081

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.